Effect of retreatment on the end-stage sudden deafness. 2012

Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
Hospital of Otorhinolaryngology Head & Neck Surgery, Institute of Otorhinolaryngology Head & Neck Surgery, Chinese PLA General Hospital, Beijing 100853, China. zhaisq@plagh.com.cn

Microcirculatory disturbance of inner ear is probably one of the important etiological factors of sudden deafness. The purpose of this study was to evaluate the effect of retreatment on the end-stage sudden deafness. For this purpose, the patients who met with the criteria for sudden deafness and showed poor response to conventional therapy over 2 months were assigned randomly to the retreatment group. Pure tone audiometry was conducted before and after retreatment among the 103 patients (112 ears). Sodium bicarbonate and dexamethasone were injected by intravenous drip for 2 days and batroxobin 5BU for 6 days. Data were analyzed using analysis of variance and t test to determine the efficacy of retreatment. These data show that the efficacy rate in retreatment group was 46.43% and the difference between before and after retreatment was significant (P < 0.01). It was, therefore, concluded that retreatment of the end-stage sudden deafness could improve the audition of the patients and should be valuable in clinics. In this regard, the combination of sodium bicarbonate and dexamethasone proved a rational therapeutic regimen for the end-stage sudden deafness. However, further large-size multicenter studies will be required for independent validation of these findings.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012103 Batroxobin A proteolytic enzyme obtained from the venom of fer-de-lance (BOTHROPS ATROX). It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-. Defibrol,Hemocoagulase,Defibrase,Reptilase,Reptilase-DEF,Reptilase DEF
D002840 Chromates Salts of chromic acid containing the CrO(2-)4 radical. Chromate
D003639 Hearing Loss, Sudden Sensorineural hearing loss which develops suddenly over a period of hours or a few days. It varies in severity from mild to total deafness. Sudden deafness can be due to head trauma, vascular diseases, infections, or can appear without obvious cause or warning. Deafness, Sudden,Sudden Deafness,Sudden Hearing Loss
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
May 1976, Nihon Jibiinkoka Gakkai kaiho,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
August 1996, Laryngo- rhino- otologie,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
April 2012, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
November 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
March 2006, Zhongguo zhen jiu = Chinese acupuncture & moxibustion,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
February 1963, Il Valsalva,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
January 1994, Acta oto-laryngologica. Supplementum,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
February 1976, Medizinische Klinik,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
June 2008, NDT plus,
Zhai Suoqiang, and Yu Ning, and Zheng Guiliang, and Zhu Yuhua, and Qin He
January 1963, Otolaryngologia polska = The Polish otolaryngology,
Copied contents to your clipboard!